Tobacco harm reduction took center stage at the recent Global Forum on Nicotine in Poland.Read More
In another contribution to the scientific study of vapor and nicotine, British American Tobacco has found that vapor does not, under the conditions of the study, impede the healing of wounds.Read More
The once-famous tobacco research station at Kutsaga, Harare, is struggling with problems created by underfunding.Read More
At the Global Forum on Nicotine, now being held in Poland, British American Tobacco is due to describe how to tell whether tobacco in a heated-tobacco product is being heated or burnt.Read More
The vapor from heated tobacco products, including that from British American Tobacco’s hybrid, iFuse, appears to offer a far-less risky experience than does the smoke from traditional cigarettes.Read More
Researchers in Germany have discovered that copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke.Read More
Analysis of the vapor from British American Tobacco’s heated tobacco product, iFuse, has underlined the importance of product development in the quest for harm reduction.Read More
Philip Morris International says the US Food and Drug Administration has established a one-year, non-binding timetable for reviewing Modified Risk Tobacco Product applications.Read More
The idea that the consumption of heat-not-burn products is considerably less risky than is the consumption of traditional tobacco cigarettes has been questioned by researchers in Switzerland.Read More
The deadline for the submission of abstracts of papers intended for presentation at CORESTA’s 2017 Joint Study Group meetings has been extended until May 26.Read More
